ARTICLES BY THIS AUTHOR
- 3/24/2020
Camber launches generic Lyrica
Camber's generic Lyrica is available in dosage strengths of 25, 50, 75, 100, 150, 200, 225, and 300 mg. - 3/24/2020
Avion introduces Gloperba
Avion's Gloperba in a liquid oral solution is now available to treat gout. - 3/24/2020
McKesson strategy exec to depart
McKesson is conducting a search for Bansi Nagji's successor, who is stepping down as executive vice president and chief strategy and business development officer, on March 31. - 3/24/2020
FDA institutes shortened approval pathway for biosimilars
The FDA has enacted a shortened regulatory pathway for certain biologics, which will allow for faster approvals and increased competition. - 3/23/2020
Lupin launches generic Diprolene
Betamethasone dipropionate ointment had a market value of approximately $21 million, according to IQVIA January 2020 data. - 3/23/2020
Dr. Reddy's debuts generic Daraprim
Daraprim (pyrimethamine) had a market value of approximately $10 million for the most recent 12 months ended January 2020, according to IQVIA. - 3/23/2020
Generic drug patent cases disrupted by COVID-19
The 30-month stay deadline surrounding generic drug patent disputes is being hampered by courts limiting access and attorneys cutting back on travel. - 3/23/2020
Retailers offer bonuses, expanded benefits as several launch hiring drives
Major retailers are awarding bonuses, expanding employee benefits and launching unprecedented hiring drives as they respond to the COVID-19 crisis. - 3/20/2020
BD, BioGX submit FDA emergency use authorization requests for COVID-19 diagnostics tests
BD's and BIOGX's new diagnostics could increase capacity of COVID-19 testing by thousands of tests per day. - 3/20/2020
CVS Health opens first COVID-19 testing site in parking lot in Massachusetts
CVS Health's first COVID-19 testing site in Shrewsbury, Mass. will initially focus on first responders and health care workers.